VVelarionINTELLIGENCE
Sign inStart free trial
Start free trial
MedTech & Diagnostics

Sotera Health Executive Compensation (FY25)

SHC · Executive and director compensation, fiscal 2022 to 2025
Chief executive, fiscal 2025
◇
Michael Petras
Latest say-on-pay support
=
May 21, 2026
Chief executive pay ratio
◇
To the median employee
Velarion Intel, $5,000/year: one seat · one year · every company we cover, with dashboards, peer screens and board-ready briefs.
See every company’s exec pay — free for 3 days, no cardSee the plan and pricing

The Sotera Health brief, $500

Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
From $500 for the board report; $900 for both.
Get the executive briefGet the board briefNo account needed.
Data as of November 5, 2026Latest filing (8-K): May 22, 2026
7 filings cited on this page
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
Sotera Health brief$500Get the executive brief
Velarion Intel, one year, every company
273 figures on this page: 269 cited to the filing that reported them, 4 calculated from figures it prints. See the citations
What changed from fiscal 2024 to fiscal 2025
The figures that moved, and by how much. Analysis of these figures is part of the Velarion platform.
Chief executive total compensation — Michael Petras: $10,392,468 → $10,656,063 (2.5% higher)
CEO pay ratio: 136:1 → 129:1 (5.1% lower)

Frequently asked questions

Answers drawn from the data on this page.
Who is Sotera Health's chief executive and what were they paid?
Michael Petras was paid $10,656,063 in total compensation as Chairman and CEO for fiscal 2025. Petras' total moved 2.5% higher from the $10,392,468 reported for fiscal 2024.
What was Sotera Health's say-on-pay result?
The say-on-pay proposal drew 97.5% support at the meeting held May 21, 2026 for fiscal 2025.
Which companies are in Sotera Health's peer group?
Companies named in the disclosed peer group include Avanos Medical, Inc., Bio-Techne Corporation, CONMED Corporation, Haemonetics Corporation and Hologic, Inc., among others.
What is Sotera Health's chief executive pay ratio?
The company reported a chief executive pay ratio of 129:1 for fiscal 2025, against median employee compensation of $82,784.

Executive compensation

Every element reported for each named executive officer, by fiscal year.
Fiscal 2022
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Michael Petras
Chairman and CEO
◇—◇◇◇—◇◇
Alexander Dimitrief
SVP, General Counsel and Secretary
◇◇◇◇◇—◇◇
Michael Rutz
President of Sterigenics
◇—◇◇◇—◇◇
Michael Biehl
Former Interim CFO
Served on an interim basis
◇——————◇
Fiscal 2023
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Michael Petras
Chairman and CEO
◇—◇◇◇—◇◇
Jonathan Lyons
SVP, CFO
◇◇◇◇◇——◇
Michael Rutz
President of Sterigenics
◇◇◇◇◇—◇◇
Alexander Dimitrief
SVP, General Counsel and Secretary
◇———◇—◇◇
Michael Biehl
Former Interim CFO
Departed during or after this year
Served on an interim basis
◇——————◇
Fiscal 2024
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Michael Petras
Chairman and CEO
◇—◇◇◇—◇◇
Michael Rutz
President of Sterigenics
◇◇◇◇◇—◇◇
Alexander Dimitrief
SVP and General Counsel
◇—◇◇◇—◇◇
Jonathan Lyons
SVP, CFO
◇—◇◇◇—◇◇
Fiscal 2025
OfficerSalaryBonusStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Michael Petras
Chairman and CEO
◇—◇—◇—◇◇
Jonathan Lyons
Senior Vice President, Chief Financial Officer
◇◇◇—◇—◇◇
Alexander Dimitrief
Former SVP and General Counsel
Departed during or after this year
◇—◇—◇—◇◇
Michael Rutz
President of Sterigenics
◇—◇—◇—◇◇
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. A negative change in pension value is shown but, as the company reports it, not included in the total.

Equity awards granted

Individual awards as disclosed: type, date, unit counts at each level, and grant date value.
Fiscal 2025
OfficerAwardGrant dateThreshold unitsTarget unitsUnits grantedMaximum unitsExercise priceGrant date fair value
Alexander DimitriefPSU◇◇◇—◇—◇
Alexander DimitriefRSU◇——◇——◇
Alexander DimitriefPSU◇———◇—◇
Jonathan LyonsRSU◇——◇——◇
Jonathan LyonsPSU◇◇◇—◇—◇
Jonathan LyonsRSU◇——◇——◇
Jonathan LyonsPSU◇———◇—◇
Michael P. RutzPSU◇———◇—◇
Michael P. RutzRSU◇——◇——◇
Michael P. RutzPSU◇◇◇—◇—◇
Michael PetrasPSU◇———◇—◇
Michael PetrasRSU◇——◇——◇
Michael PetrasPSU◇◇◇—◇—◇
Fiscal 2023, 2024 are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero. Threshold, target and maximum apply only to performance awards and are never shown for time-based or option awards.

Outstanding awards

Awards still held at fiscal year end.
As disclosed at fiscal 2025 year end
OfficerAwardUnvested unitsMarket value of unvested unitsExercise priceExpires
Michael PetrasOption◇—◇3/4/2034
RSU◇◇——
RSU◇◇——
PSU◇◇——
Option◇—◇3/6/2033
RSU◇◇——
PSU◇◇——
Alexander DimitriefOption◇—◇3/4/2034
RSU◇◇——
RSU◇◇——
PSU◇◇——
PSU◇◇——
Jonathan LyonsRSU◇◇——
Option◇—◇3/4/2034
RSU◇◇——
PSU◇◇——
RSU◇◇——
RSU◇◇——
PSU◇◇——
Option◇—◇8/7/2033
RSU◇◇——
Michael RutzRSU◇◇——
Option◇—◇3/4/2034
PSU◇◇——
RSU◇◇——
Option◇—◇3/6/2033
PSU◇◇——
RSU◇◇——
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Severance and change in control

The terms as written in the agreements.
Alexander Dimitrief
Former SVP and General Counsel · Terms as described in the company’s compensation discussion
Equity acceleration on change in control◇
Jonathan Lyons
Senior Vice President, Chief Financial Officer · Terms as described in the company’s compensation discussion
Severance multiple◇
Severance cash amount◇
Change-in-control multiple◇
Michael Petras
Chairman and CEO · Terms as described in the company’s compensation discussion
Severance multiple◇
Severance base◇
Severance cash amount◇
Change-in-control multiple◇
Change-in-control base◇
Equity acceleration on change in control◇
Benefits continuation on change in control◇
Benefits continuation◇
Michael Rutz
President of Sterigenics · Terms as described in the company’s compensation discussion
Severance multiple◇
Severance base◇
Severance cash amount◇
Change-in-control multiple◇
Change-in-control base◇
Benefits continuation on change in control◇
Benefits continuation◇

Director compensation

What each non-employee director was paid.
Fiscal 2025
DirectorFees earned in cashStock awardsOption awardsNon-equity incentivePension and deferred earningsAll other compensationTotal
Vincent K. Petrella
Lead independent director
◇◇————◇
Christopher A. Simon
◇◇————◇
Sean L. Cunningham
◇◇————◇
Ann R. Klee
◇◇————◇
James C. Neary
◇◇————◇
David E. Wheadon, M.D
◇◇————◇
Karen A. Flynn
◇◇————◇
Constantine S. Mihas
◇◇————◇
Ruoxi Chen
◇◇————◇
Robert B. Knauss
◇◇————◇
David A. Donnini, Kenneth D. Krause, Michael B. Petras Jr and Richard G. Kyle served on the board in fiscal 2025 and received no compensation for board service. Executive directors are typically paid through their executive roles, shown above.
Earlier years are included in the PDF.
A dash means the company reported no figure in that column. $0 is shown only where the filing prints a zero.

Director fee schedule

The standing retainers and premiums the board pays, as published.
Board cash retainer◇
Board equity retainer◇
Total board retainer◇
Lead independent director premium◇
Audit committee chair◇
Audit committee member◇
Compensation committee chair◇
Compensation committee member◇
Nominating and governance chair◇
Nominating and governance member◇
Equity is delivered as restricted stock units.

Disclosed peer group

The companies this board named as its compensation comparison group. The list is disclosure; the comparison is analysis.
Fiscal 2025
  • Avanos Medical, Inc. AVNS
  • Bio-Techne Corporation TECH
  • CONMED Corporation CNMD
  • Haemonetics Corporation HAE
  • Hologic, Inc. HOLX
  • Integra LifeSciences Holdings Corporation IART
  • Maravai LifeSciences Holdings, Inc. MRVI
  • Masimo Corporation MASI
  • Medpace Holdings, Inc. MEDP
  • Merit Medical Systems, Inc. MMSI
  • QuidelOrtho Corporation QDEL
  • Repligen Corporation RGEN
  • ResMed Inc. RMD
  • STERIS plc STE
  • Tandem Diabetes Care, Inc. TNDM
  • Teleflex Incorporated TFX
  • The Cooper Companies, Inc. COO
  • Waters Corporation WAT
  • West Pharmaceutical Services, Inc. WST

Say-on-pay history

Shareholder support for the compensation program, by year.
YearMeetingSupportVotes forVotes againstAbstentions
2025May 21, 2026=◇◇◇
2024May 21, 2025=◇◇◇
2023May 23, 2024=◇◇◇
2022May 25, 2023=◇◇◇

Chief executive pay ratio

As calculated and reported by the company.
Ratio
◇
Median employee compensation
◇
Chief executive total compensation
◇

Ask our research desk — $99, 24h, every figure cited to its filing.

Sample answer — “What is the CEO’s total compensation?”
- Michael Petras (Chairman and CEO), FY2025 total compensation $10,656,063 (base salary $1,130,699) [exec_comp, SEC accession 0001104659-26-040937, filed 2026-04-08]

See a complete sample report

Answered within 24 hours, every figure cited to its SEC filing. This is a one-off report: no refunds.

Email me this page as a cited PDF — sent in 2 minutes
The same figures, the same citations, formatted to hand to a committee. Nothing is added that is not on this page.
Your address is used for this and nothing else. Unsubscribe in one click.
Tell me when Sotera Health files
You get a note when this company’s compensation data changes.
Your address is used for this and nothing else. Unsubscribe in one click.

What this page does not include

Everything above is a fact Sotera Health disclosed, and it is free. Everything below is our analysis of those facts, and it is not.
Peer benchmarking
Where Sotera Health sits against its disclosed peers — percentile position by role and by pay element, and the ranking behind it. The disclosed peer group is free; comparisons across it are part of the Velarion platform.
Executive Compensation Report — $500
Written compensation analysis
A read of the pay program as designed and as paid: incentive structure, goal rigor, the alignment between the committee's stated philosophy and what the numbers show.
Executive Compensation Report — $500
Board and governance analysis
Committee composition, independence, director pay positioning, and the governance provisions read together rather than listed.
Board Governance Report — $500
Realizable pay
What the awards above are actually worth today against what they were valued at on grant, and what the gap says about the pay-for-performance link.
Velarion Intelligence
Adviser switching and vote outcomes
Two datasets covering compensation-adviser changes and what followed a contested vote. Both are part of the Velarion platform.
Inquire about access
Multiple companies at once
Cross-company views, cohort screens, and data export across the industries we cover. This page is one company; the platform is all of them.
Velarion Intelligence
Join the list for Peer Group Review
Whether Sotera Health's disclosed peer group is defensible, who names Sotera Health back in their own benchmarking group, and how pay tracks performance across it. This is the analysis a compensation consultant delivers on the group above. We will email you when it opens.
Your address is used for this and nothing else. Unsubscribe in one click.

Citations

Every figure on this page is cited to the document that reported it. Select any figure to see its citation.
273 figures on this page: 269 cited to the filing that reported them, 4 calculated from figures it prints.
269 cited to the filing
4 calculated from the filing

Documents cited

  1. 0001822479-26-000034
    Item 5.07 Submission of Matters to a Vote of Security Holders
  2. 0001104659-26-040937
    2025 Grants of Plan-Based Awards · 2025 Summary Compensation Table · CEO PAY RATIO · Compensation Discussion and Analysis · and 2 more sections
  3. 0001822479-25-000028
    Item 5.07 Submission of Matters to a Vote of Security Holders
  4. 0001104659-25-033563
    2024 Summary Compensation Table
  5. 0001822479-24-000027
  6. 0001193125-24-093193
    Summary Compensation Table
  7. 0001822479-23-000037
Cite this data
This page is free to cite. Attribution we ask for:
Velarion, “Sotera Health executive compensation, FY2022–FY2025.” https://intel.velarion.ai/comp/SHC (accessed 2026).
Short form: data: Velarion

The Sotera Health brief, $500

Positioning against its disclosed peers, the governance read, incentive design, and the CD&A alignment analysis; the full peer table; a committee-ready PDF.
From $500 for the board report; $900 for both.
Get the executive briefGet the board briefNo account needed.
7 filings cited on this page
Method: intel.velarion.ai/methodology
A report that fails to generate is refunded in full
Published by Velarion Company Intelligence
Embed this data
A small, cited view of this data for your own page or newsletter. Every embed carries a visible link back here, so the attribution travels with it.
The headline figures, each with its citation.
Connect an AI assistant
Ask your own assistant about Sotera Health and roughly 3,000 other US public companies, and get back the same figures on this page with the same citations. Free read access, no account. Add this to your assistant's connector settings.
Setup guide and the full list of questions it answers

MedTech & Diagnostics rankings

Chief executive pay — MedTech & DiagnosticsCEO pay ratio — MedTech & DiagnosticsSay-on-pay support — MedTech & Diagnostics

Peers Sotera Health discloses

The companies named in SHC's own disclosed peer group.

Avanos Medical, Inc.Bio-Techne CorporationCONMED CorporationHaemonetics CorporationHologic, Inc.Integra LifeSciences Holdings CorporationMaravai LifeSciences Holdings, Inc.Masimo CorporationMedpace Holdings, Inc.Merit Medical Systems, Inc.QuidelOrtho CorporationRepligen CorporationResMed Inc.STERIS plcTandem Diabetes Care, Inc.Teleflex IncorporatedThe Cooper Companies, Inc.Waters CorporationWest Pharmaceutical Services, Inc.

Terms on this page

Say-on-Pay VoteCEO Pay RatioMedian Employee CompensationAll companies

Free to read and cite. Redistribution or bulk use of the dataset requires a data license. Talk to us about the data license.

Cite this data
APA
Velarion Company Intelligence. (2026). Velarion database: executive and board compensation data (Version 2026Q3) [Data set]. Zenodo. https://doi.org/10.5281/zenodo.22283854
BibTeX
@misc{velarionData2026,
  author = {{Velarion Company Intelligence}},
  title = {Velarion database: executive and board compensation data},
  year = {2026},
  version = {2026Q3},
  doi = {10.5281/zenodo.22283854},
  publisher = {Zenodo},
  url = {https://doi.org/10.5281/zenodo.22283854}
}
For informational purposes only. Not investment, legal, or compensation advice.  All companies · The Pay Desk · Methodology · Terms · Privacy